“Alzheimer’s Drug-Development Program (U01 Clinical Trial Optional),” (PAR-22-047, a reissue of PAR-18-820, National Institute on Aging, application deadlines Feb. 5, June 5, and Oct. 5).
November 15, 2021
CAAR – US National Institutes of Health Funding Opportunity – November 15, 2021
Comments Off on CAAR – US National Institutes of Health Funding Opportunity – November 15, 2021
No Comments
No comments yet.
RSS feed for comments on this post.
Sorry, the comment form is closed at this time.
